AKR1C2 and AKR1C3 mediated prostaglandin D2 metabolism augments the PI3K/Akt proliferative signaling pathway in human prostate cancer cells

This publication has 42 references indexed in Scilit:

• Prostaglandin F_2α stimulates motility and invasion in colorectal tumor cells
  International Journal of Cancer, 2007
• AKT-independent Phosphorylation of TSC2 and Activation of mTOR and Ribosomal Protein S6 Kinase Signaling by Prostaglandin F2α
  Journal of Biological Chemistry, 2006
• Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor
  Proceedings of the National Academy of Sciences, 2006
• Differential involvement of ERK1-2and p38MAPKactivation on Swiss 3T3 cell proliferation induced by prostaglandin F2α
  FEBS Letters, 2006
• Partitioning of 5α-dihydrotestosterone and 5α-androstane-3α, 17β-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation
  The Journal of Steroid Biochemistry and Molecular Biology, 2004
• Activation of Phosphatidylinositol 3-Kinase/Akt Pathway by Androgen through Interaction of p85α, Androgen Receptor, and Src
  Journal of Biological Chemistry, 2003
• Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
  Leukemia, 2003
• Prostaglandin F2 Stimulates Tyrosine Phosphorylation and Mitogen-Activated Protein Kinase in Osteoblastic MC3T3-E1 Cells via Protein Kinase C Activation
  Endocrinology, 1997
• Prostacyclin in Prostatic Cancer: A Better Marker than Bone Scan or Serum Acid Phosphatase?
  British Journal of Urology, 1982
• 13,14-Dihydro-15-keto-prostaglandin F2α in Patients with Urogenital Tumors
  Urologia Internationalis, 1980